Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.
about
Risk factor thresholds: their existence under scrutinyMetabolic shifts due to long-term caloric restriction revealed in nonhuman primatesDebate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"The human paraoxonase gene cluster as a target in the treatment of atherosclerosisApolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formationAth-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in miceClinicopathological Phenotype of Autosomal Recessive Cholesterol Deficiency in Holstein CattleVascular mortality in patients with gout and in their families.Cholesteryl ester transfer protein gene polymorphisms and longevity syndromePlasma lipoproteins, lipid transport, and atherosclerosis: recent developmentsThe SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic miceLong-term incidence and prognostic factors of the progression of new coronary lesions in Japanese coronary artery disease patients after percutaneous coronary interventionIn vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia.Diet and atherosclerosis: past, present and futureAccumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy.Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.Familial hypobetalipoproteinaemia in 9 children diagnosed as the result of cord blood screening for hypolipoproteinaemia in 10 000 Danish newbornsLipoprotein measurements--a necessity for precise assessment of risk in children from high-risk familiesThe lipoproteins: predictors, protectors, and pathogens.Exome sequencing of three cases of familial exceptional longevity.Hypercholesterolaemia: not all cases warrant treatment.Segregation analysis of low levels of high-density lipoprotein cholesterol in the collaborative Lipid Research Clinics Program Family Study.Genetic influences on susceptibility to atherosclerosis in the young.High-density lipoprotein cholesterol: How High.Characterization of the promoter elements required for hepatic and intestinal transcription of the human apoB gene: definition of the DNA-binding site of a tissue-specific transcriptional factorCommon and rare gene variants affecting plasma LDL cholesterolMyocardial infarction in familial hyper-alpha and hypo-beta-lipoproteinaemia.Physical exercise and the prevention of atherosclerosis and cholesterol gall stonesExpression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.Isolation and characterization of the human apolipoprotein A-I gene.Intestinal transcription and synthesis of apolipoprotein AI is regulated by five natural polymorphisms upstream of the apolipoprotein CIII geneUse of total cholesterol/albumin ratio as an alternative to high density lipoprotein cholesterol measurement.Hypobetalipoproteinaemia--a variant of the Bassen-Kornzweig syndrome.Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA.A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity.HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?
P2860
Q24527206-21BC2FC4-C287-46BC-92FC-C76A50AC42F0Q24647414-70B829E1-9159-4102-B72D-24612990C889Q24793416-75005E84-2236-41B7-B699-A29E3ACEC84FQ26824356-D67B24E1-ABCD-4AC8-BB95-F94360A44BDEQ28330684-00DD5B83-88D6-4485-9ECC-013BC0A301EFQ28505210-36FE3B0C-E71A-4D16-9E37-5C90DF19B766Q28822508-C4F50F13-68E7-4F61-BFFA-AE9EE21D0437Q33554233-B9841A21-6932-4864-8D15-A194F11F5A9CQ33699478-CE0A4FAF-985F-4427-9609-E543CAC9EB13Q33847291-DBE678C1-3233-4E48-AD7A-476A054C0520Q33857168-B3075A5C-CE5C-4B5B-A10D-70E446B7BD4EQ33858332-516CDB8B-CDDE-4098-93B9-B5A1590A120EQ33895601-EF8A62A6-265E-46BC-A31E-351C9241366CQ34052260-9AF1A2F8-C6A0-405A-995C-D7670CA25855Q34259880-F9382295-6BF5-4A65-B61A-6C909B7ABCDCQ34477657-A9F5D5D1-88C7-4988-97F5-ABEA9B8635E1Q34628218-A37A3BBB-FC55-4F15-A989-491165FC8F42Q34988450-820B67CB-245D-47EA-84BA-74E84C6437C7Q34988473-A2A44C1A-9514-444D-921B-D383E75F85EDQ34995408-24DDF702-B6A7-4AF6-81C2-CDA610675B88Q35080576-E6932D1B-59E7-4476-841A-25EAE994C845Q35189963-A3B919BB-0777-4756-9F44-1F73AE22A643Q35199120-8CC80221-0835-405B-B4D1-055DB880FED9Q35658091-BAE0C632-751B-48B9-8666-B7B414B0B2E8Q36701072-D4EE4912-F814-42FF-A44A-CDF5E7964ACDQ36710186-1BBABB71-736C-409E-B87B-AEEBD5689567Q36711327-003DDB97-B61A-4F3C-B2F2-B7C85DAC8A25Q36714481-E31FD812-8A26-4258-A965-31BD7C01A2F3Q36715113-6376F9C5-36CD-4580-8501-3AF707F00E95Q37370951-F9049D8B-0B86-4220-B9C4-DAF59BEC3349Q37513957-B94E8FBE-9C78-4089-A639-9B02B69F1BD1Q38346805-3D289C31-D32C-4C44-B562-A7E3D58AE113Q39512768-799A32F1-0611-4A40-839B-03D17B07D3BFQ41494867-9EF67DC9-8BFB-49C3-A8DA-A7B6232AB5F7Q41668256-62160EBA-579F-47A9-ACA0-5774FBEA0D3BQ41960841-9DBE20AB-0B29-47AF-90F8-6C14541F8D52Q55257404-67044066-8BF5-4F15-9AD2-BBA6173AED5B
P2860
Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.
@en
type
label
Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.
@en
prefLabel
Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.
@en
P2093
P1476
Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.
@en
P2093
P304
P577
1976-12-01T00:00:00Z